Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited announced the resumption of land use rights for a property acquired by its subsidiary, Guangzhou Zhaokang, in 2015. The local government imposed a 20% idle land fee on the resumption, and compensation will be paid to Guangzhou Zhaokang. Additionally, the company terminated an equity transfer agreement due to the purchaser’s default, and is seeking legal advice on further actions.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It specializes in the acquisition and management of pharmaceutical assets, particularly through its subsidiary, Guangzhou Zhaokang.
YTD Price Performance: 0%
Average Trading Volume: 136,526
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$836.1M
Find detailed analytics on 0950 stock on TipRanks’ Stock Analysis page.